INS and Insulin resistance: ARBs mitigate insulin resistance by inhibiting the RAAS, leading to decreased cytokine production (including tumor necrosis factor-α), elevated adiponectin levels, and enhanced pancreatic insulin secretion and cellular insulin signaling.